Loading institutional data...
Loading institutional data...
Held by 641 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $2.74 today, the market must believe free cash flow compounds -9.3%/yr for a decade (off $1.6B normalized FCF).
The market's -9.3% is more conservative than its 8-yr track record.
2-stage DCF · 0.60B shares · net debt $7.9B
mean 8.4% · volatility σ 106% · implied rate exceeded in 4/7 yrs
Central path = implied -9.3%/yr growth; shaded band = ±1σ (106%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 20% of free cash flow, leaving room to grow it and fund buybacks. Last year: $312M dividends + $634M buybacks = $946M returned on $1.5B FCF.
1 consecutive years of dividend increases · 4%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Modest payoff on reinvested capital. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $283M covers the $181M due within a year 1.6× over. Scheduled principal only (excludes interest & revolver draws). As of 2026-04-03 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~6.9% on $8.2B of debt.
Cash of $283M fully covers short-term debt of $181M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05
Is the profit real, and how strong is the balance sheet?
FY2027 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 | FY2027 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 18.5 | 15.8 | 14.2 | 14.6 | 17.8 | 19.2 | 19.7 | 21.5 |
| Gross Profit | 81.5 | 84.2 | 85.8 | 85.4 | 82.2 | 80.8 | 80.3 | 78.5 |
| R&D | 17.1 | 13.2 | 10.5 | 9.0 | 9.4 | 8.7 | 8.4 | 8.2 |
| SG&A | 16.7 | 14.8 | 8.4 | 14.0 | 8.6 | 15.9 | 7.4 | 24.6 |
| Operating Income | 6.4 | 14.3 | 35.1 | 35.9 | 36.4 | 29.2 | 40.9 | 42.4 |
| Income Tax | 0.1 | 9.7 | 6.9 | 7.4 | -16.6 | -4.2 | 9.8 | 10.8 |
| Net Income | 1.3 | 156.1 | 21.7 | 29.9 | 40.2 | 16.0 | 16.3 | 19.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on GENVR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-08-05 · 42d old
How a revenue dollar becomes profit — FY2027
Each value shows its share of revenue below it (common-size).
| Line Item | FY2027 | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.00B 100.0% | $3.94B 100.0% | $3.80B 100.0% | $3.32B 100.0% | $2.80B 100.0% | $2.55B 100.0% | $2.49B 100.0% | $2.46B 100.0% | $2.56B 100.0% | $4.02B 100.0% |
| Cost of Revenue | $1.08B 21.5% | $776.0M 19.7% | $731.0M 19.2% | $589.0M 17.8% | $408.0M 14.6% | $362.0M 14.2% | $393.0M 15.8% | $455.0M 18.5% | $463.0M 18.1% | $853.0M 21.2% |
| Gross Profit | $3.92B 78.5% | $3.16B 80.3% | $3.07B 80.8% | $2.73B 82.2% | $2.39B 85.4% | $2.19B 85.8% | $2.10B 84.2% | $2.00B 81.5% | $2.10B 81.9% | $3.17B 78.8% |
| Research & Development | $409.0M 8.2% | $329.0M 8.4% | $332.0M 8.7% | $313.0M 9.4% | $253.0M 9.0% | $267.0M 10.5% | $328.0M 13.2% | $420.0M 17.1% | $455.0M 17.8% | $823.0M 20.5% |
| Selling, General & Admin | $1.23B 24.6% | $291.0M 7.4% | $604.0M 15.9% | $286.0M 8.6% | $392.0M 14.0% | $215.0M 8.4% | $368.0M 14.8% | $410.0M 16.7% | $487.0M 19.0% | $564.0M 14.0% |
| Total Operating Expenses | $1.80B 36.1% | $1.55B 39.4% | $1.96B 51.6% | $1.52B 45.9% | $1.38B 49.5% | $1.29B 50.7% | $1.74B 70.0% | $1.84B 75.0% | $2.25B 87.9% | $3.27B 81.3% |
| Operating Income | $2.12B 42.4% | $1.61B 40.9% | $1.11B 29.2% | $1.21B 36.4% | $1.00B 35.9% | $896.0M 35.1% | $355.0M 14.3% | $158.0M 6.4% | -$154.0M -6.0% | -$100.0M -2.5% |
| Interest Expense | $569.0M 11.4% | $578.0M 14.7% | $669.0M 17.6% | $401.0M 12.1% | $126.0M 4.5% | $144.0M 5.6% | $196.0M 7.9% | $208.0M 8.5% | $256.0M 10.0% | $208.0M 5.2% |
| Interest & Investment Income | $25.0M 0.5% | $28.0M 0.7% | $25.0M 0.7% | $15.0M 0.5% | $0 0.0% | $4.0M 0.2% | $80.0M 3.2% | $42.0M 1.7% | $24.0M 0.9% | $21.0M 0.5% |
| Other Income (Expense), net | -$40.0M -0.8% | -$3.0M -0.1% | $6.0M 0.2% | -$22.0M -0.7% | $163.0M 5.8% | $120.0M 4.7% | $660.0M 26.5% | -$57.0M -2.3% | $654.0M 25.6% | $46.0M 1.1% |
| Pretax Income | $1.51B 30.2% | $1.03B 26.1% | $447.0M 11.8% | $783.0M 23.6% | $1.04B 37.3% | $872.0M 34.2% | $819.0M 32.9% | -$107.0M -4.4% | $244.0M 9.5% | -$262.0M -6.5% |
| Income Tax Expense | $538.0M 10.8% | $386.0M 9.8% | -$160.0M -4.2% | -$551.0M -16.6% | $206.0M 7.4% | $176.0M 6.9% | $241.0M 9.7% | $3.0M 0.1% | -$720.0M -28.1% | -$26.0M -0.6% |
| Net Income | $973.0M 19.5% | $643.0M 16.3% | $607.0M 16.0% | $1.33B 40.2% | $836.0M 29.9% | $554.0M 21.7% | $3.89B 156.1% | $31.0M 1.3% | $1.14B 44.5% | -$106.0M -2.6% |
| Per Share | ||||||||||
| EPS (Basic) | $1.59 | $1.04 | $0.95 | $2.17 | $1.44 | $0.94 | $6.32 | $0.05 | $1.85 | $-0.17 |
| EPS (Diluted) | $1.57 | $1.03 | $0.95 | $2.14 | $1.41 | $0.92 | $6.05 | $0.05 | $1.70 | $-0.17 |
| Weighted Avg Shares (Basic) | 612.0M | 617.0M | 637.0M | 614.0M | 581.0M | 589.0M | 615.0M | 632.0M | 616.0M | 618.0M |
| Weighted Avg Shares (Diluted) | 619.0M | 624.0M | 642.0M | 624.0M | 591.0M | 600.0M | 643.0M | 632.0M | 668.0M | 618.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position